⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20329197 | 0.86 | — | — | |
| SCHEMBL26474203 | 0.86 | — | — | |
| SCHEMBL19760424 | 0.84 | — | — | |
| SCHEMBL19051013 | 0.84 | — | — | |
| SCHEMBL12416160 | 0.84 | — | — | |
| SCHEMBL19078924 | 0.84 | — | — | |
| SCHEMBL26253261 | 0.83 | — | — | |
| SCHEMBL25768995 | 0.83 | — | — | |
| SCHEMBL25758650 | 0.83 | — | — | |
| SCHEMBL25768481 | 0.83 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150272980-A1 | Dosing and Administration of Oligonucleotide Cancer Therapies | PRONAI THERAPEUTICS, INC. | 2015-10-01 | — | — | US | disclosed |